Advertisement

Dysphagia

, Volume 32, Issue 3, pp 449–453 | Cite as

Effect of Food Thickener on the Inhibitory Effect of Mitiglinide Tablets on Post-prandial Elevation of Blood Glucose Levels

  • Takashi TomitaEmail author
  • Hidekazu Goto
  • Kenji Sumiya
  • Tadashi Yoshida
  • Katsuya Tanaka
  • Kenzo Kudo
  • Yukinao Kohda
Original Article

Abstract

The aim of this study was to examine the effect of food thickener on the pharmacodynamics of mitiglinide (MGN), a drug belonging to a class of rapid-acting insulin secretagogues. First, MGN tablets were coated by immersion in a xanthan gum-based food-thickening agent. This treatment was shown to delay disintegration rates of MGN tablets in vitro. The pharmacodynamics of MGN after ingestion of a single oral dose of an MGN tablet, with or without food thickener immersion, were then examined in an open-label crossover study comprising 5 healthy participants. It was observed that after administration of 75 g of oral glucose, the area under the blood glucose concentration–time curve was larger for treatment with MGN tablets that had been immersed in the food thickener than for nonimmersed tablets. The maximum blood glucose level was also higher in treatments with MGN tablets that had been immersed in food thickener. The extended time of higher glucose levels associated with thickener-immersed MGN tablets given to human volunteers may be associated with the reduced disintegration rates of immersed MGN tablets as observed in the in vitro experiment. Overall, our study suggests that commercially available food thickeners influence the pharmacodynamics of MGN and that their use should therefore be carefully assessed and monitored in certain clinical situations.

Keywords

Food thickener Deglutition Mitiglinide Deglutition disorders Post-prandial elevation Blood glucose level 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Deto A, Yamagata Y, Kayashita J. Effects of temperature on the physical properties of various commercial thickening gents for dysphagia. Bull Fac Hum C Sci Pref Univ. Hiroshima. 2007;2:39–47.Google Scholar
  2. 2.
    Nakamura M, Yoshida S, Nishioka Y, Hayashi S, Suzuki Y. Categorization of commercial thickeners on the basis of their effects on the physical properties of foods. Jpn J Nutr Diet. 2012;70:59–70.CrossRefGoogle Scholar
  3. 3.
    Tomita T, Goto H, Yoshimura Y, Tsubouchi Y, Nakanishi R, Kojima C, Yoneshima M, Yoshida T, Tanaka K, Sumiya K, Kohda Y. Effect of food thickener on disintegration and dissolution of magnesium oxide tablets. Yakugaku Zasshi. 2015;135:835–40.CrossRefPubMedGoogle Scholar
  4. 4.
    Tomita T, Goto H, Sumiya K, Nakanishi R, Kojima C, Yoneshima M, Yoshida T, Tanaka K, Kohda Y. Effect of food thickener on disintegration of donepezil hydrochloride orally disintegrating tablets. Igaku no Ayumi. 2015;253:677–8.Google Scholar
  5. 5.
    Goto H, Tomita T, Sumiya K, Nakanishi R, Kojima C, Yoneshima M, Yoshida T, Tanaka K, Kohda Y. Effect of food thickener on tablet disintegration of rapid-disintegration over-the-counter drugs. J Community Pharm Pharm Sci. 2016;8:88–91.Google Scholar
  6. 6.
    Yamaguchi H, Ochiai A, Takiya H. Abstracts of papers, the 24th annual meeting of Japanese society of pharmaceutical health care and sciences, Nagoya. 2014, p. 371.Google Scholar
  7. 7.
    Tomita T, Goto H, Sumiya K, Yoshida T, Tanaka K, Kohda Y. The effect of food thickener on the inhibitory effect of voglibose oral disintegrating tablet on post-prandial elevation of blood sugar levels. Yakugaku Zasshi. 2016;136:1171–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Fujitani J, Uyama R, Okoshi H, Kayashita J, Koshiro A, Takahashi K, Maeda H, Fujishima I, Ueda K. Japanese society of dysphagia rehabilitation: classification of dysphagia modified food. Jpn J Dysphagia Rehabil. 2013;17:255–67.Google Scholar
  9. 9.
    Kurihara A. Effects of combination therapy with mitiglinide and sitagliptin on insulin and glucagon secretion. Prog Med. 2011;31:2737–41.Google Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Takashi Tomita
    • 1
    • 2
    Email author
  • Hidekazu Goto
    • 2
  • Kenji Sumiya
    • 3
  • Tadashi Yoshida
    • 4
  • Katsuya Tanaka
    • 5
  • Kenzo Kudo
    • 1
  • Yukinao Kohda
    • 2
    • 6
  1. 1.Department of Clinical Pharmaceutics and Pharmacy Practice, School of PharmacyIwate Medical UniversityMoriokaJapan
  2. 2.Department of PharmacyHospital BandoBandoJapan
  3. 3.Faculty of PharmacyIwaki Meisei UniversityIwakiJapan
  4. 4.Department of Internal MedicineHospital BandoBandoJapan
  5. 5.Department of PsychiatryHospital BandoBandoJapan
  6. 6.Faculty of Health SciencesTsukuba International UniversityTsuchiuraJapan

Personalised recommendations